Enriqueta Vallejo-Yagüe, Dr sc., is a postdoctoral researcher and team leader in the Interprofessional Primary Care Research team. Her postdoctoral research focuses on sex and gender in healthcare. She is passionate about implementing the sex and gender dimensions in health research and practice, aiming to increase the knowledge on the female body from the medical and pharmacological perspective, and to tackle gender bias. Additionally, at BIHAM, she coordinates a study aiming to improve medication use.

She studied pharmacy at the Complutense University of Madrid (2012), and trained at the Careggi University Hospital, Florence. She conducted pharmaceutical research and development at Synovo GmbH (2012-2018), being the project research leader of the European-funded project VISION, and the responsible person for the company’s orphan drugs. She undertook a Master in Pharmacoepidemiology and Pharmacovigilance by the University of Alcala and conducted the master thesis at the Medical School Twente (2018), Eschende. She gained her doctoral degree in pharmacoepidemiology at ETH Zurich, under the supervision of Prof. Andrea M. Burden (2022). Her doctoral research focussed on developing real-world evidence on immune mediated diseases, with attention to obesity and sex. She is the founder of Wall of Scientists (www.wallofscientists.com), awarded the 2022 ETH Diversity Award.

She is an active member of the Health Equity and Diversity Special Interest Group (HE&D SIG) at the International Society for Pharmacoepidemiology (ISPE), and member of the Swiss Gender Health Network (SGHN).

  • Pharmacoepidemiology
  • Sex and gender
  • Women’s health
  • Deprescribing
  • Diversity and inclusion